Quantus

Xencor company information

NASDAQ:XNCR · Nasdaq · Healthcare · sector #16
$33.26-2.21%Nov 20 close

Xencor's company information is shown as of 2026-11-20. It is a security listed on Nasdaq, ticker XNCR. There are 14 published related companies.

About this company

Xencor is a clinical-stage biopharmaceutical company that discovers and develops engineered antibody therapeutics to treat cancer and autoimmune diseases. Xencor develops and advances XmAb drug candidates and biotherapeutic drug candidates. Xencor focuses its business, research, and clinical efforts on developing and advancing a portfolio of XmAb drug candidates in oncology and autoimmune diseases.

Quantus's relationship data lists competitors: Amgen, Genmab, MacroGenics and 5 more; customers: AstraZeneca, Novartis, Johnson & Johnson.

By revenue it ranks No. 263 of the 531 companies with revenue data in Healthcare, with less than 0.1% of the sector's total revenue.

The sector is fragmented: its top three companies hold 37.1% of revenue.

Source: 10-K FY2025 · SEC, business description (filed 2026-02-25)

What changed

Auditable observations with the original numeric evidence.

매출 하락 → 마진 압박 → 현금 악화

Critical

매출이 -34.4% 감소하며 영업이익률이 -82.4%에서 -180.0%로 하락했다. 영업현금흐름도 동반 감소하여 수익-현금 순환이 약화되고 있다.

Evidence

매출 YoY -34.4% (2023→2024)영업이익률 -82.4%→-180.0%영업CF 85→-202

Factual information, not investment advice.

1 guru reporting 13F holdings — Joel Greenblatt

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F is quarterly and may be filed up to 45 days later.

Curated gurus reporting this holding

A curated subset of well-known investors — not the full institutional ownership.

Suppliers, competitors and related stocks

Major stocks in the same sector

2026-11-21 dataset

📦 ETFs holding this stock

by weight · top-10 constituents basis

Passive money holding this stock ≈ $1M(lower bound — top-10 basis, not a forecast)

Factual holdings info from daily disclosures — not a recommendation.

Look up another stock →

Xencor:“What if I buy at RSI 30?” 1 free card

Xencor notifications

Quantus Signal · live data · not investment advice · Privacy Policy